Results 31 to 40 of about 6,563 (147)

Cosmetic Adverse Reactions and Prognostic Factors: A Retrospective Cohort Study in Wuhan, China

open access: yesContact Dermatitis, EarlyView.
This study reveals that being under 20 or having a history of allergies significantly increases the risk of long‐term symptoms after a cosmetic adverse reaction. These findings help dermatologists identify high‐risk patients for proactive management and tailored preventive strategies.
Ayan Hasen   +4 more
wiley   +1 more source

Paronychia and granulation tissue formation during treatment with isotretinoin [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
This paper describes the association of two unusual side effects of treatment with isotretinoin for severe acne: paronychia and excess granulation tissue in the nails furrows.
Daniela de Almeida Figueiras   +4 more
doaj   +1 more source

Pediatric sweet syndrome

open access: yesClinical Case Reports, 2021
Pediatric Sweet syndrome is a rare dermatosis often triggered by a prodromal illness or infection and characterized histologically by a dense neutrophilic infiltrate.
Albert E. Zhou   +4 more
doaj   +1 more source

Recovery From Anorexia Nervosa: A Concept Analysis

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim Despite decades of research, we still know surprisingly little about how best to bring about lasting recovery from anorexia nervosa (AN). Furthermore, there is a lack of consensus in the research and treatment communities about what constitutes recovery from AN, or whether “recovery” is even an appropriate term to use in this context.
Sarah Ramsay, Kendra Allison
wiley   +1 more source

Involvement of Nail Apparatus in Pemphigus Vulgaris in Ethnic Poles Is Infrequent

open access: yesFrontiers in Medicine, 2018
Pemphigus vulgaris lesions have a tendency to localize around natural body orifices. The aim here was to analyze the involvement of nail apparatus in pemphigus vulgaris.
Pawel Pietkiewicz   +4 more
doaj   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami   +6 more
wiley   +1 more source

Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex

open access: yesIndian Journal of Dermatology, 2014
Epidermal growth factor receptor (EGFR) inhibitor therapy has become the standard treatment for non-small cell lung cancer and head neck malignancy. This class of drug comprises EGFR inhibitors (erlotinib and gefitinib) and monoclonal antibody (cetuximab)
Bhushan Madke   +3 more
doaj   +1 more source

Retronychia [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2018
: Retronychia is a recently described disorder caused by ingrowth of the proximal nail plate into the proximal nail fold. It is suspected when there is persistent paronychia, particularly in the setting of trauma.
Cristina Diniz Borges Figueira de Mello   +3 more
doaj   +1 more source

KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra‐Cerebral AVM

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT A 15‐year‐old female with a longstanding, unresectable intracerebral arteriovenous malformation (AVM) involving the bilateral thalami and basal ganglia presented with progressive neurologic decline. Given the inaccessibility of the intracranial lesion, a lipomatous scalp nodule overlying the AVM was biopsied for molecular testing and revealed ...
Donglin Zhang   +5 more
wiley   +1 more source

Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study

open access: yesVeterinary Dermatology, EarlyView.
Lapatinib is widely used in human oncology; however, dermatological adverse events (DAEs) are common and have been correlated with treatment efficacy. In veterinary medicine, lapatinib use in combination with piroxicam has been shown to be effective in treating canine urothelial carcinoma (UC); however, the incidence and prognostic significance of DAEs
Kosuke Horita   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy